n-(3-(aminomethyl)benzyl)acetamidine and Disease Models, Animal

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Disease Models, Animal in 55 studies

Research

Studies (55)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's32 (58.18)29.6817
2010's20 (36.36)24.3611
2020's3 (5.45)2.80

Authors

AuthorsStudies
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV1
Herms, F; Hofmann, L; Hurst, J; Joachim, SC; Kuehn, S; Mueller-Buehl, AM; Schnichels, S1
Pallone, TL; Payne, K; Zhang, Z1
Barrett-Jolley, R; Djouhri, L; Staunton, CA; Thippeswamy, T1
Han, S; Wang, B1
Anantharam, V; Gage, M; Gasser, G; Gregory-Flores, A; Hinojo-Perez, A; Olson, A; Putra, M; Puttachary, S; Sharma, S; Thippeswamy, T; Wang, C1
Bloomfield, PS; Chapple, KJ; Davies, AL; Desai, RA; Diem, R; Fairless, R; Kasti, M; Linington, C; McIntosh, PR; Murphy, MP; Smith, KJ1
Chen, TH; Liao, FT; Wang, JJ; Yang, YC2
Du, Y; Hao, L; Liu, Y; Lu, Q; Qin, W; Sheng, L; Wang, J; Wang, X; Wang, Y; Zhang, M; Zhao, T1
Breitinger, HG; El-Sayed, NS; Gad, MZ; Maher, A1
Luo, D; Putra, M; Puttachary, S; Sharma, S; Thippeswamy, A; Thippeswamy, T; Verma, S; Yang, Y1
Bennett, LD; Birch, DG; Carr, BC; Emigh, CE; Nguyen, C; Pansick, AD1
Hiroaki-Sato, VA; Joca, SR; Sales, AJ1
Bland, KI; Chaudry, IH; Choudhry, MA; Hsu, JT; Kan, WH; Raju, R; Schwacha, MG1
Dieterich, HJ; Goedhart, PT; Ince, C; Johannes, T; Klingel, K; Mik, EG; Nohé, B; Unertl, KE; Zanke, C1
Akgul, EO; Cayci, T; Cetiner, S; Ersoz, N; Guven, A; Korkmaz, A; Oztas, E; Turk, E; Uysal, B1
Benetti, LR; Conran, N; Fernandes, LG; Ferreira, HH; Guimarães, Lde A; Pelaquini, EH; Tamashiro, WM1
Gao, HM; Hong, JS; Kam, W; Wilson, B; Zhang, F; Zhou, H1
Abraldes, JG; Bosch, J; García-Pagán, JC; La Mura, V; Pasarín, M; Rodríguez-Vilarrupla, A1
Cobb, BA; Lewis, CJ1
Gobbato, NB; Leick, EA; Maciel, RG; Martins, MA; Prado, CM; Souza, FC; Tibério, IF1
Cavalcante Melo, FH; de Carvalho Lima, CN; de França Fonteles, MM; Freire Vasconcelos, L; Leite Dias, M; Moura Rocha, NF; Rodrigues Carvalho, AM; Soares Lopes, K; Vasconcelos Rios, ER1
Botten, J; Davis, IC; Hjelle, B; Matalon, S; Nolte, KB; Zajac, AJ1
Bauer, TW; Buerk, DG; Fraker, DL; Kelley, ST; Menon, C1
Asfar, P; Brückner, UB; Fröba, G; Georgieff, M; Ince, C; Nalos, M; Pittner, A; Radermacher, P; Yang, Y1
Battram, CH; Belvisi, MG; Birrell, MA; Foster, ML; Haddad, el-B; McCluskie, K; Webber, SE; Yacoub, MH1
Georgieff, M; Jauch, KW; Matejovic, M; Ploner, F; Radermacher, P; Stehr, A; Theisen, M; Tugtekin, I; Zülke, C1
Bachetti, T; Ferrari, R; Pasini, E; Suzuki, H1
Anning, PB; Evans, TW; Mitchell, JA; Price, S1
Abdelrahman, M; Cuzzocrea, S; McDonald, M; Thiemermann, C1
Bunge, MB; Chatzipanteli, K; Dietrich, WD; Marcillo, AE; Pearse, DD1
Slomiany, A; Slomiany, BL1
Alborch, E; Burguete, MC; Castillo, J; Hurtado, O; Knowles, RG; Leza, JC; Lizasoain, I; Lorenzo, P; Moro, MA; Pérez-Asensio, FJ; Salom, JB; Torregrosa, G1
Besson, VC; Bohme, GA; Jafarian-Tehrani, M; Louin, G; Marchand-Verrecchia, C; Plotkine, M; Royo, NC1
Bonnefont-Rousselot, D; Jafarian-Tehrani, M; Lerouet, D; Louin, G; Margaill, I; Palmier, B; Plotkine, M1
Mark, LA; Robinson, AV; Schulak, JA1
Mayr, FB; Spiel, AO1
Boer, R; Ghofrani, HA; Grimminger, F; Lehner, M; Maring, D; Mayer, K; Pullamsetti, SS; Rosengarten, B; Schermuly, RT; Schudt, C; Seeger, W; Weissmann, N1
Fitzsimmons, B; Hua, XY; Svensson, CI; Tang, Q; Webb, M; Yaksh, TL1
Bobadilla, NA; Chirino, YI; Cruz, C; Martínez-Martínez, CM; Pedraza-Chaverri, J; Sánchez-González, DJ; Trujillo, J1
Akita, Y; Imamura, H; Iwasaka, T; Matsuhisa, S; Moriguchi, A; Okazaki, T; Otani, H; Sato, D; Yamashita, K1
Gilroy, DW; Paul-Clark, MJ; Tomlinson, A; Willis, D; Willoughby, DA1
Beck, KF; Eberhardt, W; Pfeilschifter, J; Raslik, I; Schaefer, L; Schaefer, RM; Walpen, S1
Alvarez, E; Colón, AL; Leza, JC; Lizasoain, I; Lorenzo, P; Menchén, LA; Menchén, P; Moro, MA1
Folkerts, G; Koster, AS; Muijsers, RB; Nijkamp, FP; Postma, DS; van Ark, I; van Oosterhout, AJ1
Cerwinka, WH; Granger, DN; Grisham, MB; Krieglstein, CF; Laroux, FS; Ross, CR; Russell, JM; Salter, JW; Schuermann, G1
Courtois, Y; Goureau, O; Sennlaub, F1
Chiang, CP; Huang, CF; Lee, MY; Liu, HY; Sun, GH; Sun, KH; Tang, SJ; Tsou, YC1
Fu, J; Liu, X; Liu, Z; Ran, J; Shi, Q; Wang, N; Zheng, J; Zheng, X1
Li, Q; Liu, K; Zhang, L; Zheng, X1
Aker, S; Boengler, K; Canton, M; Deindl, E; Di Lisa, F; Heusch, G; Heusch, P; Klein, K; Konietzka, I; Menazza, S; Rassaf, T; Schulz, R; Sewell, A; van de Sand, A1
Andreadou, I; Bastounis, E; Gorgoulis, VG; Kotsinas, A; Kremastinos, D; Papalambros, E; Sigala, F; Sigalas, P1
Kennison, SD; Mercer, DW; Robinson, EK; Suliburk, JW1
Amato, A; Feo, S; Mulè, F; Serio, R; Zizzo, MG1

Trials

1 trial(s) available for n-(3-(aminomethyl)benzyl)acetamidine and Disease Models, Animal

ArticleYear
Neurological deficits caused by tissue hypoxia in neuroinflammatory disease.
    Annals of neurology, 2013, Volume: 74, Issue:6

    Topics: Amidines; Animals; Benzylamines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation; Micronutrients; Organophosphorus Compounds; Oxygen; Rats; Recovery of Function; Severity of Illness Index; Single-Blind Method; Spinal Cord Diseases; Ubiquinone

2013

Other Studies

54 other study(ies) available for n-(3-(aminomethyl)benzyl)acetamidine and Disease Models, Animal

ArticleYear
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection

2020
iNOS-inhibitor driven neuroprotection in a porcine retina organ culture model.
    Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:7

    Topics: Amacrine Cells; Amidines; Animals; Apoptosis; Benzylamines; Cell Hypoxia; Disease Models, Animal; Humans; Microglia; Neuroprotection; Neuroprotective Agents; Nitric Oxide Synthase Type II; Organ Culture Techniques; Retina; Retinal Diseases; Retinal Ganglion Cells; Swine

2020
Adaptive responses of rat descending vasa recta to ischemia.
    American journal of physiology. Renal physiology, 2018, 03-01, Volume: 314, Issue:3

    Topics: Adaptation, Physiological; Amidines; Angiotensin II; Animals; Arterioles; Benzylamines; Constriction; Disease Models, Animal; Endothelial Cells; Enzyme Inhibitors; Humans; Ischemia; Kidney; Membrane Potentials; Nitric Oxide; Nitric Oxide Synthase Type II; Pericytes; Rats, Sprague-Dawley; Renal Artery; Renal Circulation; Vasoconstriction; Vasoconstrictor Agents

2018
Inducible nitric oxide synthase inhibition by 1400W limits pain hypersensitivity in a neuropathic pain rat model.
    Experimental physiology, 2018, 04-01, Volume: 103, Issue:4

    Topics: Amidines; Animals; Benzylamines; Cytokines; Disease Models, Animal; Male; Neuralgia; Nitric Oxide; Nitric Oxide Synthase Type II; Rats; Rats, Wistar

2018
Inhibition of Inducible Nitric Oxide Synthase Attenuates Deficits in Synaptic Plasticity and Brain Functions Following Traumatic Brain Injury.
    Cerebellum (London, England), 2018, Volume: 17, Issue:4

    Topics: Amidines; Animals; Benzylamines; Brain; Brain Injuries, Traumatic; Disease Models, Animal; Enzyme Inhibitors; Excitatory Postsynaptic Potentials; Functional Laterality; In Vitro Techniques; Male; Maze Learning; Mice; Mice, Inbred C57BL; Neuronal Plasticity; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Patch-Clamp Techniques; Postural Balance; Recognition, Psychology; RNA, Messenger; Time Factors; Up-Regulation

2018
Inducible nitric oxide synthase inhibitor, 1400W, mitigates DFP-induced long-term neurotoxicity in the rat model.
    Neurobiology of disease, 2020, Volume: 133

    Topics: Amidines; Animals; Benzylamines; Brain; Disease Models, Animal; Enzyme Inhibitors; Isoflurophate; Male; Nerve Agents; Nerve Degeneration; Neuroprotective Agents; Neurotoxicity Syndromes; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley

2020
Inhibition of inducible nitric oxide synthesis ameliorates liver ischemia and reperfusion injury induced transient increase in arterial stiffness.
    Transplantation proceedings, 2014, Volume: 46, Issue:4

    Topics: Amidines; Animals; Benzylamines; Biomarkers; Cytoprotection; Disease Models, Animal; Enzyme Inhibitors; Inflammation Mediators; Liver; Liver Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Pulse Wave Analysis; Rats, Sprague-Dawley; Reperfusion Injury; Time Factors; Vascular Stiffness

2014
Inhibition of inducible nitric oxide synthase ameliorates myocardial ischemia/reperfusion injury - induced acute renal injury.
    Transplantation proceedings, 2014, Volume: 46, Issue:4

    Topics: Acute Kidney Injury; Amidines; Animals; Benzylamines; Biomarkers; Blood Pressure; Cytoprotection; Disease Models, Animal; Enzyme Inhibitors; Injections, Intraperitoneal; Kidney; Male; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Rats, Sprague-Dawley; Time Factors

2014
Inhibition of poly (ADP-ribose) polymerase and inducible nitric oxide synthase protects against ischemic myocardial damage by reduction of apoptosis.
    Molecular medicine reports, 2015, Volume: 11, Issue:3

    Topics: Amidines; Animals; Apoptosis; Benzylamines; Cardiotonic Agents; Caspase 3; Disease Models, Animal; Enzyme Inhibitors; Isoquinolines; Male; Myocardial Infarction; Myocardium; Nitric Oxide Synthase Type II; Piperidines; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Rats; Ventricular Function

2015
Overexpression of NMDAR2B in an inflammatory model of Alzheimer's disease: modulation by NOS inhibitors.
    Brain research bulletin, 2014, Volume: 109

    Topics: Alzheimer Disease; Amidines; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arginine; Benzylamines; Brain; Diflunisal; Disease Models, Animal; Enzyme Inhibitors; Exploratory Behavior; Gene Expression Regulation; Inflammation; Lipopolysaccharides; Male; Maze Learning; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Receptors, N-Methyl-D-Aspartate

2014
1400W, a highly selective inducible nitric oxide synthase inhibitor is a potential disease modifier in the rat kainate model of temporal lobe epilepsy.
    Neurobiology of disease, 2016, Volume: 93

    Topics: Amidines; Animals; Benzylamines; Disease Models, Animal; Epilepsy, Temporal Lobe; Hippocampus; Male; Neurons; Nitric Oxide Synthase Type II; Rats, Sprague-Dawley; Status Epilepticus

2016
TOWARDS A TREATMENT FOR DIABETIC RETINOPATHY: Intravitreal Toxicity and Preclinical Safety Evaluation of Inducible Nitric Oxide Synthase Inhibitors.
    Retina (Philadelphia, Pa.), 2017, Volume: 37, Issue:1

    Topics: Amidines; Animals; Aqueous Humor; Benzylamines; Diabetic Retinopathy; Disease Models, Animal; Electroretinography; Enzyme Inhibitors; Guanidines; Intraocular Pressure; Intravitreal Injections; Male; Nitric Oxide; Nitric Oxide Synthase Type II; Rabbits; Retina; Vitreous Body

2017
Participation of hippocampal nitric oxide synthase and soluble guanylate cyclase in the modulation of behavioral responses elicited by the rat forced swimming test.
    Behavioural pharmacology, 2017, Volume: 28, Issue:1

    Topics: Amidines; Animals; Arginine; Benzylamines; Disease Models, Animal; Hippocampus; Male; Nitric Oxide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Oxadiazoles; Rats; Rats, Wistar; Soluble Guanylyl Cyclase; Stress, Psychological; Swimming; Time Factors

2017
Selective inhibition of iNOS attenuates trauma-hemorrhage/resuscitation-induced hepatic injury.
    Journal of applied physiology (Bethesda, Md. : 1985), 2008, Volume: 105, Issue:4

    Topics: Amidines; Animals; Benzylamines; Blood Pressure; Chemokines; Cytokines; Disease Models, Animal; Enzyme Inhibitors; Fluid Therapy; Glutathione Transferase; Hypoxia-Inducible Factor 1, alpha Subunit; Intercellular Adhesion Molecule-1; Isoenzymes; Liver; Liver Diseases; Male; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Peroxidase; Rats; Rats, Sprague-Dawley; Resuscitation; Shock, Hemorrhagic; Tyrosine; Wounds and Injuries

2008
Effects of 1400W and/or nitroglycerin on renal oxygenation and kidney function during endotoxaemia in anaesthetized rats.
    Clinical and experimental pharmacology & physiology, 2009, Volume: 36, Issue:9

    Topics: Acute Kidney Injury; Amidines; Anesthesia, General; Animals; Benzylamines; Biomarkers; Creatinine; Disease Models, Animal; Endotoxemia; Enzyme Inhibitors; Fluid Therapy; Glomerular Filtration Rate; Hemodynamics; Kidney; Lipopolysaccharides; Male; Microcirculation; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type II; Nitroglycerin; Oxidation-Reduction; Oxygen Consumption; Rats; Rats, Wistar; Renal Circulation; RNA, Messenger; Time Factors

2009
Comparison of the efficacy of melatonin and 1400W on renal ischemia/reperfusion injury: a role for inhibiting iNOS.
    Renal failure, 2009, Volume: 31, Issue:8

    Topics: Amidines; Animals; Antioxidants; Benzylamines; Disease Models, Animal; Enzyme Inhibitors; Kidney; Kidney Diseases; Male; Melatonin; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Reperfusion Injury

2009
Role of the Mac-1 and VLA-4 integrins, and concomitant Th2-cytokine production, in nitric oxide modulated eosinophil migration from bone marrow to lungs in allergic mice.
    International immunopharmacology, 2011, Volume: 11, Issue:2

    Topics: Amidines; Animals; Benzylamines; Bone Marrow; Chemotaxis, Leukocyte; Cytokines; Disease Models, Animal; Enzyme Inhibitors; Eosinophils; Female; Hypersensitivity; Integrin alpha4beta1; Leukocyte Count; Lung; Macrophage-1 Antigen; Mice; Mice, Inbred BALB C; Nitric Oxide; Nitric Oxide Synthase Type II; Ovalbumin; Th2 Cells

2011
Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease.
    Environmental health perspectives, 2011, Volume: 119, Issue:6

    Topics: alpha-Synuclein; Amidines; Animals; Animals, Genetically Modified; Benzylamines; Disease Models, Animal; Injections, Intraperitoneal; Lewy Bodies; Lipopolysaccharides; Mice; NADPH Oxidases; Nerve Degeneration; Neurodegenerative Diseases; Nitric Oxide Synthase Type II; Onium Compounds; Oxidative Stress; Parkinson Disease; Substantia Nigra

2011
Insulin resistance and liver microcirculation in a rat model of early NAFLD.
    Journal of hepatology, 2011, Volume: 55, Issue:5

    Topics: Acetylcholine; Amidines; Animals; Benzylamines; Diet, High-Fat; Disease Models, Animal; Endothelium; Enzyme Inhibitors; Fatty Liver; Hypoglycemic Agents; Insulin; Insulin Resistance; Liver; Liver Circulation; Male; Metformin; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Non-alcoholic Fatty Liver Disease; Phosphorylation; Rats; Rats, Wistar; Up-Regulation; Vasodilation; Vasodilator Agents

2011
Adaptive immune defects against glycoantigens in chronic granulomatous disease via dysregulated nitric oxide production.
    European journal of immunology, 2011, Volume: 41, Issue:9

    Topics: Adaptive Immunity; Adoptive Transfer; Amidines; Animals; Antigen Presentation; Benzylamines; Cells, Cultured; Disease Models, Animal; Glycoproteins; Granuloma; Granulomatous Disease, Chronic; Humans; Interferon-gamma; Macrophages, Peritoneal; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidase 2; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase; Th1 Cells

2011
Effects of corticosteroid, montelukast and iNOS inhibition on distal lung with chronic inflammation.
    Respiratory physiology & neurobiology, 2013, Jan-15, Volume: 185, Issue:2

    Topics: Acetates; Amidines; Animals; Anti-Inflammatory Agents; Benzylamines; Chronic Disease; Cyclopropanes; Cytokines; Dexamethasone; Disease Models, Animal; Enzyme Inhibitors; Eosinophils; Guinea Pigs; Lung; Male; Ovalbumin; Pneumonia; Quinolines; Statistics, Nonparametric; Sulfides

2013
Involvement of the nitric oxide/cyclic guanylate monophosphate pathway in the pilocarpine-induced seizure model in mice.
    Pharmacology, 2013, Volume: 91, Issue:3-4

    Topics: Amidines; Animals; Arginine; Benzylamines; Cyclic GMP; Disease Models, Animal; Enzyme Inhibitors; Guanidines; Guanylate Cyclase; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxadiazoles; Pilocarpine; Receptors, Cytoplasmic and Nuclear; Seizures; Soluble Guanylyl Cyclase

2013
Elevated generation of reactive oxygen/nitrogen species in hantavirus cardiopulmonary syndrome.
    Journal of virology, 2002, Volume: 76, Issue:16

    Topics: Adolescent; Adult; Amidines; Animals; Benzylamines; Blood Proteins; Case-Control Studies; Disease Models, Animal; Disease Vectors; Enzyme Inhibitors; Female; Hantavirus Pulmonary Syndrome; Humans; Lymphocytic Choriomeningitis; Lymphocytic choriomeningitis virus; Male; Mice; Mice, Inbred NZB; Middle Aged; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Orthohantavirus; Peromyscus; Reactive Nitrogen Species; Reactive Oxygen Species; Sin Nombre virus; Tyrosine

2002
Acidosis plus melphalan induces nitric oxide-mediated tumor regression in an isolated limb perfusion human melanoma xenograft model.
    Surgery, 2002, Volume: 132, Issue:2

    Topics: Acidosis; Amidines; Animals; Antineoplastic Agents, Alkylating; Apoptosis; Benzylamines; Disease Models, Animal; Enzyme Inhibitors; Female; Hindlimb; Humans; Melanoma; Melphalan; Nitric Oxide; Rats; Rats, Nude; Regional Blood Flow; Skin Neoplasms; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2002
Mechanisms of inducible nitric oxide synthase (iNOS) inhibition-related improvement of gut mucosal acidosis during hyperdynamic porcine endotoxemia.
    Intensive care medicine, 2003, Volume: 29, Issue:2

    Topics: Acidosis; Amidines; Animals; Benzylamines; Blood Gas Analysis; Disease Models, Animal; Drug Evaluation, Preclinical; Endotoxemia; Hemodynamics; Ileum; Intestinal Mucosa; Laser-Doppler Flowmetry; Microcirculation; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Prospective Studies; Random Allocation; Spectrophotometry; Swine

2003
Pharmacological assessment of the nitric-oxide synthase isoform involved in eosinophilic inflammation in a rat model of sephadex-induced airway inflammation.
    The Journal of pharmacology and experimental therapeutics, 2003, Volume: 304, Issue:3

    Topics: Amidines; Animals; Benzylamines; Bronchi; Cytokines; Dexamethasone; Dextrans; Disease Models, Animal; Enzyme Inhibitors; Eosinophilia; Eosinophils; Inflammation; Lung; Male; Neutrophils; Nitric Oxide Synthase; Protein Isoforms; Rats; Rats, Sprague-Dawley; Rats, Wistar; RNA, Messenger

2003
Effect of combining nicotinamide as a PARS-inhibitor with selective iNOS blockade during porcine endotoxemia.
    Intensive care medicine, 2003, Volume: 29, Issue:6

    Topics: Amidines; Animals; Benzylamines; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Endotoxemia; Energy Metabolism; Female; Hemodynamics; Intestinal Mucosa; Lipopolysaccharides; Liver Circulation; Male; Niacinamide; Nitric Oxide Synthase; Poly(ADP-ribose) Polymerase Inhibitors; Prospective Studies; Pulmonary Circulation; Random Allocation; Splanchnic Circulation; Swine; Time Factors

2003
Species-specific modulation of the nitric oxide pathway after acute experimentally induced endotoxemia.
    Critical care medicine, 2003, Volume: 31, Issue:5

    Topics: Amidines; Animals; Benzylamines; Blood Pressure; Breath Tests; Disease Models, Animal; Drug Evaluation, Preclinical; Endotoxemia; Escherichia coli Infections; Lipopolysaccharides; Luminescent Measurements; Lung; Male; Myocardium; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Prospective Studies; Rabbits; Random Allocation; Rats; Species Specificity

2003
Type II nitric oxide synthase activity is cardio-protective in experimental sepsis.
    European journal of pharmacology, 2003, Jul-04, Volume: 472, Issue:1-2

    Topics: Amidines; Animals; Benzylamines; Cardiotonic Agents; Disease Models, Animal; Enzyme Inhibitors; Heart; Heart Function Tests; Lipopolysaccharides; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; Sepsis

2003
Tyrphostin reduces the organ injury in haemorrhagic shock: role of inducible nitric oxide synthase.
    Resuscitation, 2003, Volume: 58, Issue:3

    Topics: Amidines; Animals; Benzylamines; Creatine Kinase; Disease Models, Animal; Immunohistochemistry; Kidney; Liver; Multiple Organ Failure; Nitric Oxide; Nitric Oxide Synthase; Pancreas; Protein-Tyrosine Kinases; Rats; Shock, Hemorrhagic; Tyrphostins

2003
Comparison of iNOS inhibition by antisense and pharmacological inhibitors after spinal cord injury.
    Journal of neuropathology and experimental neurology, 2003, Volume: 62, Issue:11

    Topics: Amidines; Animals; Annexins; Astrocytes; Benzylamines; Blood-Brain Barrier; Cell Count; Cell Death; Disease Models, Animal; Drug Administration Routes; Enzyme Inhibitors; Female; Fluorescent Dyes; Glial Fibrillary Acidic Protein; Guanidines; Immunoglobulin G; Immunohistochemistry; Laminectomy; Motor Neurons; Neutrophils; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oligodeoxyribonucleotides, Antisense; Organic Chemicals; Peroxidase; Phosphopyruvate Hydratase; Propidium; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries

2003
Platelet-activating factor mediates Porphyromonas gingivalis lipopolysaccharide interference with salivary mucin synthesis via phosphatidylinositol 3-kinase-dependent constitutive nitric-oxide synthase activation.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2004, Volume: 55, Issue:1 Pt 1

    Topics: Amidines; Androstadienes; Animals; Apoptosis; Benzylamines; Cell Survival; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Ginkgolides; Glucosamine; Lactones; Lipopolysaccharides; Mucins; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Platelet Activating Factor; Porphyromonas gingivalis; Rats; Rats, Sprague-Dawley; Saliva; Salivary Glands; Sublingual Gland; Tritium; Tumor Necrosis Factor-alpha; Up-Regulation; Wortmannin

2004
Inhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia.
    Neurobiology of disease, 2005, Volume: 18, Issue:2

    Topics: Adenosine Triphosphate; Amidines; Amino Acid Transport System X-AG; Animals; Benzylamines; Brain; Cerebral Infarction; Cytoprotection; Disease Models, Animal; Down-Regulation; Enzyme Inhibitors; Glutamic Acid; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Male; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; Stroke; Treatment Outcome

2005
1400W, a potent selective inducible NOS inhibitor, improves histopathological outcome following traumatic brain injury in rats.
    Nitric oxide : biology and chemistry, 2005, Volume: 12, Issue:2

    Topics: Amidines; Animals; Benzylamines; Brain Injuries; Calcium; Disease Models, Animal; Enzyme Inhibitors; Male; Nerve Tissue Proteins; Neurons; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Time Factors

2005
Lack of iNOS induction in a severe model of transient focal cerebral ischemia in rats.
    Experimental neurology, 2005, Volume: 195, Issue:1

    Topics: Amidines; Analysis of Variance; Animals; Anticoagulants; Benzylamines; Blotting, Western; Brain; Calcium; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Edetic Acid; Enzyme Inhibitors; Inhibitory Concentration 50; Ischemic Attack, Transient; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Time Factors

2005
Inhibition of nitric oxide synthase reduces renal ischemia/reperfusion injury.
    The Journal of surgical research, 2005, Volume: 129, Issue:2

    Topics: Amidines; Animals; Benzylamines; Creatinine; Disease Models, Animal; Endothelins; Enzyme Inhibitors; Kidney Tubules; Male; Nitric Oxide; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tyrosine

2005
NO-synthase inhibition in sepsis.
    Thrombosis and haemostasis, 2006, Volume: 95, Issue:4

    Topics: Amidines; Animals; Benzylamines; Disease Models, Animal; Enzyme Inhibitors; Hemodynamics; Humans; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Sepsis; Shock, Septic

2006
Effect of nitric oxide synthase (NOS) inhibition on macro- and microcirculation in a model of rat endotoxic shock.
    Thrombosis and haemostasis, 2006, Volume: 95, Issue:4

    Topics: Amidines; Animals; Benzylamines; Disease Models, Animal; Enzyme Inhibitors; Epinephrine; Hemoglobins; Male; Microcirculation; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Rats; Rats, Wistar; Shock, Septic

2006
Inhibition of spinal constitutive NOS-2 by 1400W attenuates tissue injury and inflammation-induced hyperalgesia and spinal p38 activation.
    The European journal of neuroscience, 2007, Volume: 25, Issue:10

    Topics: Amidines; Animals; Benzylamines; Carrageenan; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Hyperalgesia; Inflammation; Inflammation Mediators; Male; MAP Kinase Signaling System; Neurons, Afferent; Nitric Oxide; Nitric Oxide Synthase Type II; Nociceptors; p38 Mitogen-Activated Protein Kinases; Pain Measurement; Rats; Rats, Sprague-Dawley; Spinal Cord

2007
Selective iNOS inhibition reduces renal damage induced by cisplatin.
    Toxicology letters, 2008, Jan-04, Volume: 176, Issue:1

    Topics: Aldehydes; Amidines; Animals; Antineoplastic Agents; Benzylamines; Cisplatin; Disease Models, Animal; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Kidney; Kidney Diseases; Male; Malondialdehyde; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Rats; Rats, Wistar; RNA, Messenger; Tyrosine

2008
Angiotensin II type 1 receptor blocker preserves tolerance to ischemia-reperfusion injury in Dahl salt-sensitive rat heart.
    American journal of physiology. Heart and circulatory physiology, 2008, Volume: 294, Issue:6

    Topics: Aldehydes; Amidines; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Benzylamines; Disease Models, Animal; Enzyme Activation; Enzyme Inhibitors; Hypertension; Losartan; Male; Malondialdehyde; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphorylation; Rats; Rats, Inbred Dahl; Sodium Chloride, Dietary; Tiopronin; Up-Regulation; Ventricular Function, Left

2008
Nitric oxide synthase inhibitors have opposite effects on acute inflammation depending on their route of administration.
    Journal of immunology (Baltimore, Md. : 1950), 2001, Jan-15, Volume: 166, Issue:2

    Topics: Acute Disease; Amidines; Animals; Antioxidants; Benzylamines; Carrageenan; Disease Models, Animal; Drug Administration Schedule; Edema; Enzyme Inhibitors; Free Radical Scavengers; Inflammation; Inflammation Mediators; Injections; Injections, Intraperitoneal; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; omega-N-Methylarginine; Pleura; Pleurisy; Rats; Rats, Wistar; Superoxides; Thiourea

2001
Nitric oxide induces MIP-2 transcription in rat renal mesangial cells and in a rat model of glomerulonephritis.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2001, Volume: 15, Issue:3

    Topics: Amidines; Animals; Benzylamines; Chemokine CXCL2; Chemokines; Disease Models, Animal; Enzyme Inhibitors; Gene Expression Regulation; Genes, Reporter; Glomerular Mesangium; Glomerulonephritis; Interleukin-1; Kidney Glomerulus; Lysine; Mutagenesis, Site-Directed; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Promoter Regions, Genetic; Rats; Recombinant Fusion Proteins

2001
N-(3-(aminomethyl)benzyl)acetamidine, an inducible nitric oxide synthase inhibitor, decreases colonic inflammation induced by trinitrobenzene sulphonic acid in rats.
    Life sciences, 2001, Jun-15, Volume: 69, Issue:4

    Topics: Amidines; Animals; Benzylamines; Blotting, Western; Colitis; Colon; Disease Models, Animal; Drug Administration Schedule; Enzyme Activation; Enzyme Inhibitors; Female; Injections, Intraperitoneal; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peroxidase; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid

2001
Apocynin and 1400 W prevents airway hyperresponsiveness during allergic reactions in mice.
    British journal of pharmacology, 2001, Volume: 134, Issue:2

    Topics: Acetophenones; Amidines; Animals; Antioxidants; Benzylamines; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Enzyme Inhibitors; Eosinophils; Hypersensitivity; Immunoglobulin E; Immunohistochemistry; Interferon-gamma; Interleukin-4; Interleukin-5; Lung; Male; Mice; Mice, Inbred BALB C; Neutrophils; Nitric Oxide Synthase; Ovalbumin; Specific Pathogen-Free Organisms; Tyrosine

2001
Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide.
    The Journal of experimental medicine, 2001, Nov-05, Volume: 194, Issue:9

    Topics: Amidines; Animals; Benzylamines; Colitis, Ulcerative; Colon; Dextran Sulfate; Digestive System; Digestive System Physiological Phenomena; Disease Models, Animal; Enzyme Inhibitors; Gene Expression; Humans; Inflammatory Bowel Diseases; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; NADPH Oxidases; Neutrophil Infiltration; Neutrophils; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Phosphoproteins; Reactive Oxygen Species; Specific Pathogen-Free Organisms; Superoxide Dismutase; Superoxides; Time Factors; Tumor Necrosis Factor-alpha

2001
Inducible nitric oxide synthase mediates retinal apoptosis in ischemic proliferative retinopathy.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2002, May-15, Volume: 22, Issue:10

    Topics: Aging; Amidines; Animals; Animals, Newborn; Apoptosis; Benzylamines; Cell Count; Crosses, Genetic; Diabetic Retinopathy; Disease Models, Animal; Drug Administration Routes; Enzyme Inhibitors; Immunohistochemistry; In Situ Nick-End Labeling; Ischemia; Mice; Mice, Inbred Strains; Mice, Knockout; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxygen; Proteins; Retina; Retinal Diseases; Retinal Vein Occlusion; Tyrosine

2002
Nitric oxide suppresses LPS-induced inflammation in a mouse asthma model by attenuating the interaction of IKK and Hsp90.
    Experimental biology and medicine (Maywood, N.J.), 2015, Volume: 240, Issue:4

    Topics: Animals; Asthma; Cells, Cultured; Cytokines; Disease Models, Animal; Female; HSP90 Heat-Shock Proteins; I-kappa B Kinase; Imines; Inflammation; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred BALB C; Nitric Oxide; Nitric Oxide Synthase; Ovalbumin; S-Nitroso-N-Acetylpenicillamine; Signal Transduction

2015
1400W ameliorates acute hypobaric hypoxia/reoxygenation-induced cognitive deficits by suppressing the induction of inducible nitric oxide synthase in rat cerebral cortex microglia.
    Behavioural brain research, 2017, 02-15, Volume: 319

    Topics: Animals; Annexin A5; Apoptosis; Cells, Cultured; Cognition Disorders; Disease Models, Animal; Gene Expression Regulation; Hypoxia; Imines; Lipid Peroxidation; Malondialdehyde; Maze Learning; Microglia; Nerve Tissue Proteins; Nitric Oxide; Nitric Oxide Synthase Type II; Oxygen; Rats; Rats, Sprague-Dawley; Tyrosine

2017
The dynamic detection of NO during stroke and reperfusion in vivo.
    Brain injury, 2009, Volume: 23, Issue:5

    Topics: Animals; Disease Models, Animal; Enzyme Inhibitors; Hippocampus; Imines; Indazoles; Infusions, Intravenous; Male; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Stroke

2009
Increased inducible nitric oxide synthase and arginase II expression in heart failure: no net nitrite/nitrate production and protein S-nitrosylation.
    American journal of physiology. Heart and circulatory physiology, 2010, Volume: 299, Issue:2

    Topics: Animals; Arginase; Arginine; Blotting, Western; Cardiac Pacing, Artificial; Disease Models, Animal; Enzyme Inhibitors; Heart Failure; Heart Rate; Imines; Male; Microscopy, Confocal; Myocardial Contraction; Myocardium; Nitrates; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitrites; Protein Processing, Post-Translational; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stroke Volume; Superoxides; Up-Regulation; Ventricular Function, Left

2010
Relationship between iNOS expression and aortic cell proliferation and apoptosis in an elastase-induced model of aorta aneurysm and the effect of 1400 W administration.
    Surgery, 2005, Volume: 137, Issue:4

    Topics: Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apoptosis; Cell Division; Disease Models, Animal; Enzyme Inhibitors; Imines; Immunohistochemistry; Male; Malondialdehyde; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Pancreatic Elastase; Rats; Rats, Wistar

2005
Rat gastric injury after lipopolysaccharide: role of inducible nitric oxide synthase.
    Surgery, 2005, Volume: 138, Issue:3

    Topics: Animals; Disease Models, Animal; Female; Gastric Juice; Gastric Mucosa; Imines; Lipopolysaccharides; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats

2005
Evidence for a role of inducible nitric oxide synthase in gastric relaxation of mdx mice.
    Neurogastroenterology and motility, 2006, Volume: 18, Issue:6

    Topics: Animals; Disease Models, Animal; Enzyme Inhibitors; Imines; Male; Mice; Mice, Inbred mdx; Muscle Relaxation; Muscle, Smooth; Muscular Dystrophy, Duchenne; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Organ Culture Techniques; Oxadiazoles; Quinoxalines; Receptors, Vasoactive Intestinal Peptide; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stomach; Vasoactive Intestinal Peptide

2006